Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
7.49
-0.11 (-1.45%)
Nov 28, 2025, 4:00 PM EST - Market closed
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $194.77 million as of December 1, 2025. Its market cap has decreased by -54.73% in one year.
Market Cap
194.77M
Enterprise Value
63.99M
1-Year Change
-54.73%
Ranking
Category
Stock Price
$7.49
Market Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has increased from $166.07M to $194.77M, an increase of 17.28%. That is a compound annual growth rate of 8.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 194.77M | -57.73% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
| Nov 14, 2023 | 166.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 968.00B |
| Johnson & Johnson | 494.72B |
| AbbVie | 401.34B |
| UnitedHealth Group | 298.38B |
| AstraZeneca | 287.99B |
| Merck & Co. | 259.37B |
| Novartis AG | 249.49B |
| Abbott Laboratories | 224.18B |